UPenn
Thermo Fisher Scientific's IonTorrent Genexus platform can provide cancer panel results in about a day, but data on clinical impact of the fast turnaround has not yet been produced.
The South San Francisco-based startup recently published two studies showing the performance of its tests for predicting preterm birth and preeclampsia.
The blood test detects the presence of seven proteins to determine if a patient is likely to respond to the FDA-approved treatment siltuximab.
Multi-Analyte Liquid Biopsy Panel May Aid in Pancreatic Cancer Detection, Staging
The panel's developers at UPenn hope to validate and commercialize a non-invasive assay through a startup called Chip Diagnostics.
Nearly 3,500 patients were referred to the Roberts Individualized Medical Genetics Center for exome sequencing or other testing during the clinical program's first four years.